SI080011: Hydrochlorothiazide-13C d2 label-new which keep the glycan inert

which keep the glycan inert during synthesis and are removed under mild base (e

it is also compatible with thiol-gold chemistry for surface immobilization

C16H14O12SNa2 / 476

/ β-GlcNAc-PEG3-Azide / β-GlcNAc-PEG3-N3

UniProt position 264-278

SI080011: Hydrochlorothiazide-13C d2 label-new which keep the glycan inertC613CH6D2ClN15N2O4S2 300. 74 Hypertension, Congestive Heart Failure, Kidney Stone Hydrochlorothiazide 13C d2 6 Chloro 3,4 dihydro 2H 1,2,4 benzothiadiazine 13C d2 sulfonamide 1,1 Dioxide; Apo hydro 13C,15N2 d2; Aquazide h 13C 15N2 d2; Dichlotride 13C 15N2 d2; Diurizid 13C 15N2 d2; Oretic 13C 15N2 d2; HCTZ 13C 15N2 d2; HZT 13C 15N2 d2